Stryker Corporation
Stryker Corporation Announces Organizational Restructuring and Segment Recast
Summary
Stryker Corporation has announced a reorganization of its business segments, combining its orthopaedic instruments portfolio with the Mako and enabling technologies portfolio to form a new Ortho Tech business. This restructuring aims to simplify the customer experience and accelerate innovation. As a result, the company will continue to report two business segments: MedSurg and Neurotechnology, and Orthopaedics. The filing includes a recast of the prior period financial statements to reflect these segment changes, as required by SEC rules. This filing does not amend or restate the previously issued financial statements but provides updated segment information in conjunction with the change in business structure.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement